|
1
|
Fox CS, Matsushita K, Woodward M, Bilo HJ,
Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi
T, et al: Associations of kidney disease measures with mortality
and end-stage renal disease in individuals with and without
diabetes: A meta-analysis. Lancet. 380:1662–1673. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang L, Zhou Y, Zhou F, Yu X, Liu J, Liu
Y, Zhu Y, Wang W and Chen N: Altered expression of long noncoding
and messenger RNAs in diabetic nephropathy following treatment with
rosiglitazone. Biomed Res Int. 2020(1360843)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang ZS, Qiu T, Liu XH, Zhou JQ, Chen ZB,
Wang L and Zhang L, Shen Y and Zhang L: Tripterysium glycosides
preconditioning attenuates renal ischemia/reperfusion injury in a
rat model. Int Urol Nephrol. 48:213–221. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Xu X, Pan X and Li S: Prospective analysis
of the efficacy of beraprost sodium combined with alprostadil on
diabetic nephropathy and influence on rennin-angiotensin system and
TNF-α. Exp Ther Med. 19:639–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang XM, Yang KN, Gao W and Cao XJ:
Analysis of effect and adverse reactions of enalapril on diabetic
nephropathy. J Clin Med Pract. (3)2012.
|
|
6
|
Cao Y, Yun N and Zou A: Meta-analysis of
ADR induced by tripterysium glycosides tablet. China Pharmacy.
29:125–130. 2018.
|
|
7
|
Feng X, Zhao J, Ding J, Shen X, Zhou J and
Xu Z: lncRNA Blnc1 expression and its effect on renal fibrosis in
diabetic nephropathy. Am J Transl Res. 11:5664–5672.
2019.PubMed/NCBI
|
|
8
|
Gao J, Wang W, Wang F and Guo C:
lncRNA-NR_033515 promotes proliferation, fibrogenesis and
epithelial-to-mesenchymal transition by targeting miR-743b-5p in
diabetic nephropathy. Biomed Pharmacother. 106:543–552.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Alvarez ML and DiStefano JK: Functional
characterization of the plasmacytoma variant translocation 1 gene
(PVT1) in diabetic nephropathy. PLoS One. 6(e18671)2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Alvarez ML, Khosroheidari M, Eddy E and
Kiefer J: Role of microRNA 1207-5P and its host gene, the long
non-coding RNA Pvt1, as mediators of extracellular matrix
accumulation in the kidney: Implications for diabetic nephropathy.
PLoS One. 8(e77468)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li N, Jia T and Li Y: lncRNA NEAT1
accelerates the occurrence and development of diabetic nephropathy
by sponging miR-23c. Eur Rev Med Pharmacol Sci. 24:1325–1337.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang H and Guo H: Long non-coding RNA
NORAD induces cell proliferation and migration in prostate cancer.
J Int Med Res. 47:3898–3904. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tong L, Ao Y, Zhang H, Wang K, Wang Y and
Ma Q: Long noncoding RNA NORAD is upregulated in epithelial ovarian
cancer and its downregulation suppressed cancer cell functions by
competing with miR-155-5p. Cancer Med. 8:4782–4791. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li J, Xu X, Wei C, Liu L and Wang T: Long
noncoding RNA NORAD regulates lung cancer cell proliferation,
apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.
Int J Clin Exp Pathol. 13:1–13. 2020.PubMed/NCBI
|
|
16
|
Tao W, Li Y, Zhu M, Li C and Li P: lncRNA
NORAD promotes proliferation and inhibits apoptosis of gastric
cancer by regulating miR-214/Akt/mTOR axis. Onco Targets Ther.
12:8841–8851. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qi H, Yao L and Liu Q: NORAD affects the
progression of diabetic nephropathy through targeting miR-520h to
upregulate TLR4. Biochem Biophys Res Commun. 521:190–195.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang G, Sun H, Zhang Y, Zhao H, Fan W, Li
J, Lv Y, Song Q, Li J, Zhang M and Shi H: Characterization of
dysregulated lncRNA-mRNA network based on ceRNA hypothesis to
reveal the occurrence and recurrence of myocardial infarction. Cell
Death Discov. 4(35)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen L, Nan A, Zhang N, Jia Y, Li X, Ling
Y, Dai J, Zhang S, Yang Q, Yi Y and Jiang Y: Circular RNA 100146
functions as an oncogene through direct binding to miR-361-3p and
miR-615-5p in non-small cell lung cancer. Mol Cancer.
18(13)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jiang ZH, Tang YZ, Song HN, Yang M, Li B
and Ni CL: miRNA-342 suppresses renal interstitial fibrosis in
diabetic nephropathy by targeting SOX6. Int J Mol Med. 45:45–52.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sun T, Liu Y, Liu L and Ma F: MicroRNA-544
attenuates diabetic renal injury via suppressing glomerulosclerosis
and inflammation by targeting FASN. Gene.
723(143986)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
He M, Wang J, Yin Z, Zhao Y, Hou H, Fan J,
Li H, Wen Z, Tang J, Wang Y, et al: MiR-320a induces diabetic
nephropathy via inhibiting MafB. Aging (Albany NY). 11:3055–3079.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yao T, Zha D, Gao P, Shui H and Wu X:
MiR-874 alleviates renal injury and inflammatory response in
diabetic nephropathy through targeting toll-like receptor-4. J Cell
Physiol. 234:871–879. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen HO, Zhang L, Tang ZY and Gong ZM:
MiR-485-5p promotes the development of osteoarthritis by inhibiting
cartilage differentiation in BMSCs. Eur Rev Med Pharmacol Sci.
22:3294–3302. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wu J, Lu K, Zhu M, Xie X, Ding Y, Shao X,
Chen Y, Liu J, Xu M, Xu Y, et al: miR-485 suppresses inflammation
and proliferation of mesangial cells in an in vitro model of
diabetic nephropathy by targeting NOX5. Biochem Biophys Res Commun.
521:984–990. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang XL, Hao YJ, Wang B, Gu XL, Wang XX
and Sun JF: Long noncoding RNA NORAD promotes the progression of
retinoblastoma by sponging miR 136-5p/PBX3 axis. Eur Rev Med
Pharmacol Sci. 24(4055)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tian Q, Yan X, Yang L, Liu Z, Yuan Z, Shen
Z and Zhang Y: lncRNA NORAD promotes hepatocellular carcinoma
progression via regulating miR-144-3p/SEPT2. Am J Transl Res.
12:2257–2266. 2020.PubMed/NCBI
|
|
28
|
Wan Y, Yao Z, Chen W and Li D: The lncRNA
NORAD/miR-520a-3p facilitates malignancy in non-small cell lung
cancer via PI3k/Akt/mTOR signaling pathway. Onco Targets Ther.
13:1533–1544. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang HQ, Ni HF, Ma KL and Zou JH: ANGPTL2
regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects
the progression of renal fibrosis in diabetic nephropathy. Am J
Transl Res. 11:5472–5486. 2019.PubMed/NCBI
|
|
31
|
Hsieh PF, Liu SF, Hung TJ, Hung CY, Liu
GZ, Chuang LY, Chen MF, Wang JL, Shi MD, Hsu CH, et al: Elucidation
of the therapeutic role of mitochondrial biogenesis transducers
NRF-1 in the regulation of renal fibrosis. Exp Cell Res. 349:23–31.
2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kaur H, Chien A and Jialal I:
Hyperglycemia induces Toll like receptor 4 expression and activity
in mouse mesangial cells: Relevance to diabetic nephropathy. Am J
Physiol Renal Physiol. 303:F1145–F1150. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sortica DA, Crispim D, Zaffari GP,
Friedman R and Canani LH: The role of ecto-nucleotide
pyrophosphatase/phosphodiesterase 1 in diabetic nephropathy. Arq
Bras Endocrinol Metabol. 55:677–685. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Burcelin R, Serino M, Chabo C,
Blasco-Baque V and Amar J: Gut microbiota and diabetes: From
pathogenesis to therapeutic perspective. Acta Diabetol. 48:257–273.
2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gao Y, Chen ZY, Wang Y, Liu Y, Ma JX and
Li YK: Long non-coding RNA ASncmtRNA-2 is upregulated in diabetic
kidneys and high glucose-treated mesangial cells. Exp Ther Med.
13:581–587. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cheng J, Cheng L, Tang Y, Li H, Peng W and
Huang S: Inhibition of lncRNA Dlx6os1 decreases cell proliferation
and fibrosis and increases cell apoptosis in diabetic nephropathy.
Int J Clin Exp Pathol. 11:3302–3309. 2018.PubMed/NCBI
|
|
37
|
Ma J, Zhao N, Du L and Wang Y:
Downregulation of lncRNA NEAT1 inhibits mouse mesangial cell
proliferation, fibrosis, and inflammation but promotes apoptosis in
diabetic nephropathy. Int J Clin Exp Pathol. 12:1174–1183.
2019.PubMed/NCBI
|
|
38
|
Liang YZ, Dong J, Zhang J, Wang S, He Y
and Yan YX: Identification of neuroendocrine stress
response-related circulating microRNAs as biomarkers for type 2
diabetes mellitus and insulin resistance. Front Endocrinol
(Lausanne). 9(132)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang J, Gu JY, Chen ZS, Xing KC and Sun
B: Astragalus polysaccharide suppresses palmitate-induced apoptosis
in human cardiac myocytes: The role of Nrf1 and antioxidant
response. Int J Clin Exp Pathol. 8:2515–2524. 2015.PubMed/NCBI
|
|
40
|
Zhang M, Wang Z, Li B, Sun F, Chen A and
Gong M: Identification of microRNA-363-3p as an essential regulator
of chondrocyte apoptosis in osteoarthritis by targeting NRF1
through the p53-signaling pathway. Mol Med Rep. 21:1077–1088.
2020.PubMed/NCBI View Article : Google Scholar
|
